University Hospital Erlangen
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Private
- Established
- 1815-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uk-erlangen.de
Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia
Completed
- Conditions
- Exercise-induced Rise of Body TemperatureX-Linked Hypohidrotic Ectodermal Dysplasia
- Interventions
- Device: Skin cooling devices
- First Posted Date
- 2010-06-03
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 28
- Registration Number
- NCT01135888
- Locations
- π©πͺ
University Hospital Erlangen, Erlangen, Bavaria, Germany
Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal Dysplasia
Completed
- Conditions
- Hypohidrotic Ectodermal Dysplasia
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2011-09-14
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 65
- Registration Number
- NCT01109290
- Locations
- π©πͺ
University Hospital Erlangen, Erlangen, Bavaria, Germany
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
Phase 2
Completed
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2015-09-25
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 79
- Registration Number
- NCT00324779
- Locations
- π©πͺ
Medizinische Hochschule Hannover, Hannover, Germany
π©πͺKlinikum Bremen-Mitte, Bremen, Germany
π©πͺUniversity Medical Center Hamburg - Eppendorf, Hamburg, Germany
Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
Phase 1
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 82
- Registration Number
- NCT00074230
- Locations
- π©πͺ
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen, Erlangen, Germany
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 1
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 23
- Registration Number
- NCT00056134
- Locations
- π©πͺ
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen, Erlangen, Germany
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 1
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- University Hospital Erlangen
- Target Recruit Count
- 62
- Registration Number
- NCT00053391
- Locations
- π©πͺ
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen, Erlangen, Germany
Β© Copyright 2025. All Rights Reserved by MedPath